Zentiva Group, a.s., headquartered in the Czech Republic, is a prominent player in the pharmaceutical industry, specialising in generic and over-the-counter medicines. Founded in 1998, the company has established a strong presence across Central and Eastern Europe, focusing on delivering high-quality, affordable healthcare solutions. Zentiva's core product offerings include a diverse range of generic pharmaceuticals, which are distinguished by their commitment to quality and accessibility. The company has achieved significant milestones, including expanding its portfolio and enhancing its manufacturing capabilities, positioning itself as a trusted provider in the market. With a dedication to innovation and patient-centric solutions, Zentiva continues to strengthen its market position, contributing to improved health outcomes across the regions it serves.
How does Zentiva Group, a.s.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Real Estate Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Zentiva Group, a.s.'s score of 14 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Zentiva Group, a.s., headquartered in the Czech Republic, currently does not have publicly available carbon emissions data for the most recent year. However, the company has made significant commitments towards climate action. Zentiva is committed to near-term reduction targets, although specific numerical targets have not been disclosed. As of January 2024, Zentiva has not committed to a net-zero target, indicating a focus on immediate emissions reduction rather than long-term carbon neutrality. The company operates within the Pharmaceuticals, Biotechnology, and Life Sciences sector, which is increasingly under pressure to address climate impacts. Zentiva's commitment to reducing its carbon footprint aligns with industry standards and reflects a growing trend among pharmaceutical companies to enhance sustainability practices. While specific emissions figures are not available, the company's proactive stance on climate commitments suggests a dedication to improving its environmental performance in the future.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Zentiva Group, a.s. is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.